Comparison of post-authorisation measures from regulatory authorities with additional evidence requirements from the HTA body in Germany – are additional data requirements by the Federal Joint Committee justified?

OBJECTIVES: The aim of this study was to compare post-authorisation measures (PAMs) from the European Medicines Agency (EMA) with data requests in fixed-termed conditional appraisals of early benefit assessments from the German Federal Joint Committee (G-BA). METHODS: Medicinal products with complet...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Health Econ Rev
Main Authors: Ruof, Jörg, Staab, Thomas, Dintsios, Charalabos-Markos, Schröter, Jakob, Schwartz, Friedrich Wilhelm
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2016
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042914/
https://ncbi.nlm.nih.gov/pubmed/27687714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13561-016-0124-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares